H. E. Scholtz

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

Gert Ulrich Kuerzel, U. Shukla, H. E. Scholtz et al. · Current Medical Research and Opinion · 2003 · 130 citations

Medicine, Endocrinology, Pharmacology +17

Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

H. E. Scholtz, S. G. Pretorius, D. H. Wessels et al. · Diabetologia · 2005 · 122 citations

Medicine, Endocrinology, Pharmacokinetics +11

Insulin Glulisine, a New Rapid-Acting Insulin Analogue, Displays a Rapid Time-Action Profile in Obese Non-Diabetic Subjects

R. H. A. Becker, Annke Frick, F. Burger et al. · Experimental and Clinical Endocrinology & Diabetes · 2005 · 94 citations

Medicine, Pharmacokinetics, Pharmacology +17

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Pharmacokinetics and Absolute Oral Bioavailability of an 800-mg Oral Dose of Telithromycin in Healthy Young and Elderly Volunteers

Claudio Perret, B. Lenfant, Estelle Weinling et al. · Chemotherapy · 2002 · 73 citations

Pharmacy, Pharmacokinetics, Pharmacology +14